Quality of life in schizophrenia: A review of the literature from 1995 to 2000
β Scribed by Jaya Pinikahana; Brenda Happell; Judy Hope; Nicholas A. Keks
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 97 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1324-3780
No coin nor oath required. For personal study only.
β¦ Synopsis
ABSTRACT:
The measurement of the quality of life of patients diagnosed with psychiatric disorders has become central to evaluating the effectiveness of treatments offered by Australian mental health services. The importance of quality of life as an indicator of the outcomes of interventions has been reflected by a large body of research seeking to measure the impact of variables such as gender, ethnicity and duration of illness on the measurable quality of life of an individual diagnosed with schizophrenia. This study aims to review and synthesize the recent literature in which quality of life has been measured by the use of at least one quality of life instrument. It is concludes that while the measurement of quality of life is valuable as a measure of outcomes, it should be treated as only one means of doing so.
π SIMILAR VOLUMES
African Americans are more likely to present with advanced stages of cancer at the time of diagnosis, and their survival rates continue to lag behind those of Caucasian survivors. Although the need to address the quality of life (QOL) of cancer survivors is well documented, little is known about the
The state of current research in the psychosocial and neurocognitive functioning of primary brain tumor patients, particularly those with gliomas, is reviewed. Specific instruments that have been used to evaluate psychosocial and neurocognitive functioning in this population are reviewed. Suggestion
## Abstract ## Background The prevention of suicide is a national and international policy priority. Old age is an important predictor of completed suicide. Suicide rates in old age differ markedly from country to country but there is a general trend towards increasing rates with increasing age. I
## Abstract Economic evaluations alongside randomised controlled trials (RCTs) are increasingly being designed to prospectively collect patientβspecific resource use and preferenceβbased health status (utility) data. This paper examines the ways in which preferenceβbased health status (utility) dat